• Development of a novel cell based therapy for the treatment of severe haemophilia A.

    Development of a novel cell based therapy for the treatment of severe haemophilia A.

  • The European Union has awarded HemAcure with about 5.6 Million Euro for three years within Horizon 2020.

    The European Union has awarded HemAcure with about 5.6 Million Euro for three years within Horizon 2020.

  • The bleeding disease haemophilia A is caused by genetic deficiency in clotting factor VIII.

    The bleeding disease haemophilia A is caused by genetic deficiency in clotting factor VIII.

  • The European Union has awarded PRONIA with 6 Million Euro within the 7th Framework Programme.

    The European Union has awarded PRONIA with 6 Million Euro within the 7th Framework Programme.

  • 1700 study participants are being recruited for PRONIA in six European centres and one in Australia.

    1700 study participants are being recruited for PRONIA in six European centres and one in Australia.

  • Psychoses typically commence in the most productive and critical period of life – late adolescence and early adulthood.

    Psychoses typically commence in the most productive and critical period of life – late adolescence and early adulthood.

  • The European Union has awarded PRONIA with 6 Million Euro within the 7th Framework Programme.

    The European Union has awarded PRONIA with 6 Million Euro within the 7th Framework Programme.

  • 1700 study participants are being recruited for PRONIA in six European centres and one in Australia.

    1700 study participants are being recruited for PRONIA in six European centres and one in Australia.

  • Psychoses typically commence in the most productive and critical period of life – late adolescence and early adulthood.

    Psychoses typically commence in the most productive and critical period of life – late adolescence and early adulthood.

The ProjectTeamNews
Search
Home
Top

HemAcure on @twitter

News Section

11/04/2016

Project Flyer

The HemAcure Project Flyer is now available! Read more

Newsletter Subscription

Please fill in the information of your subscription.

 

You have already subscribed to Newsletter Recipients and wish to update or terminate your subscription? Click here!

Social Media

Follow us on Twitter! @HemAcure_EU

HemAcure Facebook fanpage